SteadyMed Ltd.
The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. SteadyMed Ltd. is not very popular among insiders. Tradey thinks it is not wise to invest in SteadyMed Ltd..
Log in to see more information.
SteadyMed Ltd. engages in the research, development, and manufacture of pharmaceutical products thro...
News
Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer
PR Newswire Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer PR Newswire CAMBRIDGE, Mass. and BERKELEY...\n more…